Anna Rybachuk

ORCID: 0000-0001-5306-5412 · 1 paper in corpus
2025
·doi:10.20944/preprints202510.1376.v1

Background: /Objectives: For decades, only native allergen extracts with a high incidence of adverse drug reactions (ADRs) were available for allergen-specific immunotherapy (AIT) - in general administered subcutaneously - to treat allergy…